The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 16, 2026
Filed:
Jun. 10, 2020
Applicant:
Novartis Ag, Basel, CH;
Inventors:
Bruno Galli, Seltisberg, CH;
Jean-Marie Glantzmann, Michelbach-le-Bas, FR;
Arnaud Grandeury, Helfrantzkirch, FR;
Klaus-Peter Moll, Basel, CH;
Martin Mueller-Zsigmondy, Freiburg, DE;
Karsten Putzbach, Basel, CH;
Dirk Spickermann, Staufen, DE;
Hubert Thoma, Pfaffenweiler, DE;
Mike Ufer, Allschwil, CH;
Assignee:
NOVARTIS AG, Basel, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/404 (2006.01); A61J 3/02 (2006.01); A61J 3/10 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 9/50 (2006.01); A61K 31/4045 (2006.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 31/404 (2013.01); A61J 3/02 (2013.01); A61J 3/10 (2013.01); A61K 9/1652 (2013.01); A61K 9/1682 (2013.01); A61K 9/2004 (2013.01); A61K 9/2072 (2013.01); A61K 9/28 (2013.01); A61K 9/50 (2013.01); A61K 9/5089 (2013.01); A61K 31/4045 (2013.01); A61K 47/38 (2013.01);
Abstract
Drug products in the form of modified release formulations comprising the drug substance (−)-(3aR,4S,7aR)-4-Hydroxy-4m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester (AFQ056), as well as processes for making such drug products are provided. The drug products are useful in treating patients with Parkinson's disease and exhibiting L-dopa induced dyskinesia.